1
|
Diabate M, Munro P, Garcia E, Jacquel A, Michel G, Obba S, Goncalves D, Luci C, Marchetti S, Demon D, Degos C, Bechah Y, Mege JL, Lamkanfi M, Auberger P, Gorvel JP, Stuart LM, Landraud L, Lemichez E, Boyer L. Escherichia coli α-hemolysin counteracts the anti-virulence innate immune response triggered by the Rho GTPase activating toxin CNF1 during bacteremia. PLoS Pathog 2015; 11:e1004732. [PMID: 25781937 PMCID: PMC4363529 DOI: 10.1371/journal.ppat.1004732] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2014] [Accepted: 02/06/2015] [Indexed: 12/02/2022] Open
Abstract
The detection of the activities of pathogen-encoded virulence factors by the innate immune system has emerged as a new paradigm of pathogen recognition. Much remains to be determined with regard to the molecular and cellular components contributing to this defense mechanism in mammals and importance during infection. Here, we reveal the central role of the IL-1β signaling axis and Gr1+ cells in controlling the Escherichia coli burden in the blood in response to the sensing of the Rho GTPase-activating toxin CNF1. Consistently, this innate immune response is abrogated in caspase-1/11-impaired mice or following the treatment of infected mice with an IL-1β antagonist. In vitro experiments further revealed the synergistic effects of CNF1 and LPS in promoting the maturation/secretion of IL-1β and establishing the roles of Rac, ASC and caspase-1 in this pathway. Furthermore, we found that the α-hemolysin toxin inhibits IL-1β secretion without affecting the recruitment of Gr1+ cells. Here, we report the first example of anti-virulence-triggered immunity counteracted by a pore-forming toxin during bacteremia. The pathogenic potentials of most microbes depend on a repertoire of virulence factors. Despite major progress in the understanding of the molecular mechanisms underlying the activities of bacterial effectors, little is known about how they cooperate during infection to overcome host immune defenses and promote microbial persistence. Here, we investigated the roles of two uropathogenic Escherichia coli (UPEC) effectors that are co-ordinately expressed, α-hemolysin (HlyA) and cytotoxic necrotizing factor 1 (CNF1). We demonstrated that the HlyA toxin is critical for bacterial stability in the blood and showed that one important role of HlyA is to inhibit the CNF1-induced host response. Collectively, these findings reveal why the coordinated activities of HlyA and CNF1 are necessary for the full virulence of UPEC. Moreover, they unravel a HlyA-driven counter-defense mechanism used by bacteria to facilitate their survival.
Collapse
Affiliation(s)
- Mamady Diabate
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; Laboratoire de Bactériologie, CHU de Nice, Hôpital l'Archet, Nice, France
| | - Patrick Munro
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France
| | - Elsa Garcia
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France
| | - Arnaud Jacquel
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Mort Cellulaire, Differentiation et Cancer, Nice, France
| | - Gregory Michel
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France
| | - Sandrine Obba
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Mort Cellulaire, Differentiation et Cancer, Nice, France
| | - Diogo Goncalves
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Mort Cellulaire, Differentiation et Cancer, Nice, France
| | - Carmelo Luci
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; CNRS UMR7275, IPMC, Sophia Antipolis, France
| | - Sandrine Marchetti
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Mort Cellulaire, Differentiation et Cancer, Nice, France
| | - Dieter Demon
- Department of Medical Protein Research, VIB, Ghent, Belgium; Department of Biochemistry, Ghent University, Ghent, Belgium
| | - Clara Degos
- Aix-Marseille University UM 2, INSERM U 1104, CNRS UMR 7280, Marseille, France
| | - Yassina Bechah
- Unité de Recherche sur les Maladies Infectieuses Tropicales et Emergentes, CNRS UMR 6236, Faculté de Médecine, Marseille, France
| | - Jean-Louis Mege
- Unité de Recherche sur les Maladies Infectieuses Tropicales et Emergentes, CNRS UMR 6236, Faculté de Médecine, Marseille, France
| | - Mohamed Lamkanfi
- Department of Medical Protein Research, VIB, Ghent, Belgium; Department of Biochemistry, Ghent University, Ghent, Belgium
| | - Patrick Auberger
- Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Mort Cellulaire, Differentiation et Cancer, Nice, France
| | - Jean-Pierre Gorvel
- Aix-Marseille University UM 2, INSERM U 1104, CNRS UMR 7280, Marseille, France
| | - Lynda Maria Stuart
- Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America
| | - Luce Landraud
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France; Laboratoire de Bactériologie, CHU de Nice, Hôpital l'Archet, Nice, France
| | - Emmanuel Lemichez
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France
| | - Laurent Boyer
- INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la relation hôte pathogènes, Nice, France; Université de Nice-Sophia-Antipolis, UFR Médecine, Nice, France
| |
Collapse
|